Raymond James Trust’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$924K Hold
22,036
0.02% 521
2024
Q2
$900K Buy
22,036
+1,649
+8% +$65.6K 0.02% 507
2024
Q1
$845K Hold
20,387
0.02% 511
2023
Q4
$825K Buy
20,387
+5,258
+35% +$201K 0.02% 510
2023
Q3
$592K Hold
15,129
0.02% 571
2023
Q2
$615K Hold
15,129
0.02% 579
2023
Q1
$633K Hold
15,129
0.02% 554
2022
Q4
$659K Hold
15,129
0.02% 510
2022
Q3
$587K Buy
15,129
+2,434
+19% +$104K 0.02% 526
2022
Q2
$538K Hold
12,695
0.02% 567
2022
Q1
$578K Buy
12,695
+3,245
+34% +$144K 0.02% 579
2021
Q4
$458K Hold
9,450
0.01% 681
2021
Q3
$450K Hold
9,450
0.02% 658
2021
Q2
$458K Hold
9,450
0.02% 641
2021
Q1
$437K Hold
9,450
0.02% 642
2020
Q4
$450K Buy
9,450
+2,600
+38% +$118K 0.02% 588
2020
Q3
$294K Buy
6,850
+300
+5% +$12.8K 0.01% 700
2020
Q2
$267K Buy
+6,550
New +$264K 0.01% 711

Other funds holding BME

Raymond James Trust's BME Position: Q3 2024 in Review

Raymond James Trust held its BlackRock Health Sciences Trust (BME) position steady in Q3 2024 at 22,036 shares worth $924K. The position accounts for 0.02% of the portfolio, ranked #521.

Raymond James Trust first reported a position in BME in Q2 2020 and has held it in 18 quarters since. 73 funds tracked by Wall St. Rank hold BME as of Q3 2024.

  • Raymond James Trust held 22,036 shares of BlackRock Health Sciences Trust worth $924K as of Q3 2024.
  • Raymond James Trust left its BlackRock Health Sciences Trust share count unchanged in Q3 2024.
  • BlackRock Health Sciences Trust made up 0.02% of Raymond James Trust's portfolio in Q3 2024, its #521 holding.
  • Raymond James Trust first reported a position in BlackRock Health Sciences Trust in Q2 2020 and has held it in 18 quarters since.
  • 73 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q3 2024.

Based on Raymond James Trust's 13F filing for Q3 2024, filed 12 Nov 2024.